Stay updated with breaking news from Hold Letter. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
09.05.2023 - Robbins LLP reminds investors that a shareholder filed a class action on behalf of all persons and entities that purchased Fulcrum Therapeutics, Inc. (NASDAQ: FULC) common stock between March 3, 2022 and March 8, 2023. Fulcrum is a clinical-stage ...
Will they this time, based on what we've seen up to this point, the answer would seem like no. but however this is a different phase. as you noted. and there is upside for the white house playing a role in this. keep in mind if the white house declines to participate or help out with this part of the process, jerry nadler has the option based on this is characterized to shut the white house out. so there is incentive to participate but the question remains will they, wolf. >> i understand more deposition transcript have just been released. what are you learning. >> reporter: the last two trans...